Lung cancer is the most commonly diagnosed cancer across the globe and it serves as the primary reason for cancer deaths. In the recent years, oncology has developed through multiple advancements which lead to better patient outcomes whereas lung cancer immunotherapy stands as a leading treatment option for patients who suffer from advanced or metastatic lung cancer.
International patients choose India as their preferred medical destination for lung cancer treatment because the country is equipped with experienced and highly skilled oncologists, advanced medical facilities and affordable treatment options. Doctors use chemotherapy and radiation therapy as standard lung cancer treatments but they now use immunotherapy to treat patients with advanced disease.
EdhaCare, the top medical tourism company in India provides comprehensive care from medical consultation and treatment planning to visa assistance and travel coordination services to create a seamless patient experience.
What is Immunotherapy for Lung Cancer?
Immunotherapy for lung cancer in India functions as a modern method. The treatment enhances the body’s immunity to enable better detection and destruction of cancer cells. The immune system cannot detect cancer cells because they have developed methods to conceal themselves.
The drugs used in immunotherapy treatment stop cancer cells from sending out essential signals that enable their secret movements. The immune system gains the ability to detect and fight tumors after the signals from the cancer cells become blocked. The body uses its defensive mechanisms to fight cancer through immunotherapy which operates differently from Chemotherapy and Radiation Therapy that destroy cancer cells directly.
The method demonstrates strong effectiveness against
- Advanced lung cancer and
- Metastatic lung cancer and
- Patients who do not respond well to chemotherapy.
Chemotherapy and Radiation Therapy for Lung Cancer
The primary treatment methods for lung cancer before immunotherapy were Chemotherapy and Radiation Therapy.
Chemotherapy
Chemotherapy uses powerful drugs to kill rapidly dividing cancer cells. The treatment serves multiple purposes:
- The treatment shrinks tumors before surgical procedures.
- The treatment eliminates remaining cancer cells after surgical procedures.
- The treatment helps advanced lung cancer patients because it controls tumor development.
Radiation Therapy
Radiation therapy uses high-energy beams to destroy cancer cells. The treatment serves multiple purposes:
- The treatment targets localized tumors.
- The treatment helps advanced lung cancer patients through symptom management.
- The treatment uses chemotherapy as its companion.
Chemotherapy and radiation therapy work effectively yet they harm healthy cells which leads to adverse reactions. This is why immunotherapy for lung cancer is increasingly being used alongside or instead of traditional treatments.
Common Immunotherapy Drugs for Lung Cancer
Lung cancer treatment in India uses multiple immune checkpoint inhibitors. The medications treat cancer by blocking proteins which stop immune cells from attacking tumors.
Commonly used drugs include:
- Pembrolizumab
- Nivolumab
- Atezolizumab
- Durvalumab
- Ipilimumab
The treatment plan specifies that patients receive their medications through intravenous infusion at 2 to 4 week intervals.
Doctors select the most suitable drug based on:
- Cancer type (NSCLC or SCLC)
- PD-L1 biomarker levels
- Stage of the disease
- Patient’s overall health
Immunotherapy for Lung Cancer Stage 1, 2 and 3
- Immunotherapy for lung cancer treatment is used together with standard therapies to enhance the body’s capacity to fight cancer.
- Doctors use surgical procedures as the primary treatment method for stage 1 and stage 2 lung cancer while they provide immunotherapy as an adjuvant therapy after surgery to eliminate tiny cancer remnants and decrease the chances of cancer returning.
- Doctors treat patients with stage 3 lung cancer who have cancer that has spread to nearby lymph nodes but not to distant organs through a treatment combination of Chemotherapy and Radiation Therapy for Lung Cancer and immunotherapy.
- Research evidence shows that immunotherapy treatment in stage 3 disease can extend tumor control duration while it may increase patient survival rates.
- Through its ability to activate the body’s immune system for cancer cell detection and destruction, immunotherapy has evolved as an advanced lung cancer treatment methods.
Immunotherapy for Lung Cancer Stage 4
Patients with stage 4 lung cancer experience better treatment results through recent advancements in immunotherapy treatments.
Stage 4 lung cancer means the cancer has spread to other organs such as:
- Brain
- Liver
- Bones
- Adrenal glands
Surgery becomes impossible in these situations because oncologists must treat patients through systemic therapies which include:
- Immunotherapy
- Chemotherapy
- Targeted therapy
- Combination treatments
Stage 4 Lung Cancer Immunotherapy Life Expectancy
Doctors need to perform an examination to provide accurate answers for patients experiencing stage 4 lung cancer who want to know about their life expectancy with immunotherapy treatment.
The immunotherapy treatment for lung cancer treatment has shown better results for patients compared to the standard treatment options that existed before.
Research and clinical observations suggest:
- Some patients experience long-term disease control.
- The combination of immunotherapy and chemotherapy treatment has resulted in better survival rates for patients.
- Patients with tumours that show PD-L1 biomarker expression will experience strong treatment results.
- Patients who show a positive response to treatment will experience an extended life span that exceeds their original life expectancy.
The life expectancy of patients with stage 4 lung cancer who receive immunotherapy treatment depends on multiple factors which include
- Tumor genetics
- Overall health of the patient
- Response to treatment
- Early detection of metastasis
Immunotherapy for Lung Cancer Life Expectancy
The lung cancer life expectancy for immunotherapy varies based on the type of lung cancer and the patient’s immune response. The immunotherapy treatment for lung cancer provides different life expectancy results depending on the specific lung cancer type and the patient’s immune system capacities.
For some patients, immunotherapy helps:
- Slow tumour growth
- Reduce tumour size
- Improve overall survival
- Maintain better quality of life
How successful is Immunotherapy for Lung Cancer?
The success of immunotherapy depends on the type of lung cancer and certain biological markers.
Clinical studies show:
- Response rates range from 20% to 40% in many patients.
- Higher success rates occur in patients with high PD-L1 expression.
- Combination therapy with chemotherapy leads to better outcomes.
Immunotherapy is particularly beneficial for non-small cell lung cancer (NSCLC), which accounts for about 85% of lung cancer cases.
Although not every patient responds to treatment, those who do often experience significant improvements.
Lung Cancer Cost in India for Immunotherapy
One of the reasons that many international patients select India as their destination for medical treatment originates from the fact that India provides affordable packages for immunotherapy for lung cancer treatment.
The cost depends on:
- Type of immunotherapy drug
- Number of treatment cycles Hospital and
- Oncologist fees Diagnostic tests
On average:
Immunotherapy for lung cancer price in India ranges between ₹1, 50, 000 to ₹4, 00, 000 per cycle.
Side Effects of immunotherapy for lung cancer
Common side effects of immunotherapy for lung cancer include:
- Fatigue
- Skin rash
- Fever
- Loss of appetite
- Diarrhoea
- Joint pain
In rare cases, the immune system may attack healthy organs, leading to:
- Lung inflammation
- Liver inflammation
- Thyroid problems
- Intestinal inflammation
Most side effects for immunotherapy are manageable with early medical attention and supportive care.
Who is the Best Candidate for Immunotherapy?
Immunotherapy may be recommended to the patient whose:
- Lung cancer is advanced or metastatic.
- Tumours express PD-L1 biomarkers.
- Chemotherapy doesn’t work for their tumours.
- Surgical intervention cannot be done.
The usual practice is to perform biomarker testing prior to treatment recommendation.
FAQs
- How successful is immunotherapy for lung cancer?
Immunotherapy success rates differ among patients, yet research demonstrates that patients with advanced non-small cell lung cancer (NSCLC) benefit from immunotherapy because it enhances their survival rates and helps control their tumours.
- Can immunotherapy treat stage 4 lung cancer?
Yes, immunotherapy as a treatment for stage 4 lung cancer helps to slow down cancer growth and reduce tumour size.
- Is immunotherapy better than chemotherapy for lung cancer?
In several cases, immunotherapy may provide long lasting response than the traditional Chemotherapy and Radiation Therapy for Lung Cancer, especially in advanced stages.
Conclusion
Immunotherapy for lung cancer has transformed cancer treatment worldwide. The body’s immune system becomes active through immunotherapy which treats lung cancer with better survival rates and improved life quality.
International patients come to India for lung cancer treatment because the country combines its experienced oncologists with modern cancer centres and its low-cost treatment options. The Indian Council of Medical Research publishes cancer statistics which demonstrate the increasing efforts dedicated to early diagnosis, advanced therapies and research programs that aim to enhance lung cancer survival rates. Ongoing clinical research and medical innovation develop immunotherapy into a future lung cancer treatment that will serve as a major treatment method for multiple patients.